Halyard Health, Inc. (HYH) Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its stake in Halyard Health, Inc. (NYSE:HYH) by 23.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 878,558 shares of the medical instruments supplier’s stock after acquiring an additional 169,194 shares during the period. JPMorgan Chase & Co. owned 1.88% of Halyard Health worth $34,509,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Meadow Creek Investment Management LLC raised its stake in shares of Halyard Health by 1.1% in the first quarter. Meadow Creek Investment Management LLC now owns 2,660 shares of the medical instruments supplier’s stock worth $101,000 after acquiring an additional 28 shares during the last quarter. Glen Harbor Capital Management LLC raised its stake in shares of Halyard Health by 1.1% in the first quarter. Glen Harbor Capital Management LLC now owns 3,230 shares of the medical instruments supplier’s stock worth $123,000 after acquiring an additional 34 shares during the last quarter. Patten Group Inc. raised its stake in shares of Halyard Health by 0.4% in the first quarter. Patten Group Inc. now owns 19,629 shares of the medical instruments supplier’s stock worth $769,000 after acquiring an additional 75 shares during the last quarter. Somerset Trust Co raised its stake in shares of Halyard Health by 0.7% in the second quarter. Somerset Trust Co now owns 12,618 shares of the medical instruments supplier’s stock worth $495,000 after acquiring an additional 90 shares during the last quarter. Finally, State Treasurer State of Michigan raised its stake in shares of Halyard Health by 0.5% in the first quarter. State Treasurer State of Michigan now owns 18,920 shares of the medical instruments supplier’s stock worth $721,000 after acquiring an additional 100 shares during the last quarter. 91.02% of the stock is owned by institutional investors.

Shares of Halyard Health, Inc. (HYH) opened at 45.30 on Friday. The company has a market capitalization of $2.12 billion, a P/E ratio of 43.56 and a beta of 1.76. The company’s 50 day moving average is $43.40 and its 200-day moving average is $39.60. Halyard Health, Inc. has a 1-year low of $31.59 and a 1-year high of $46.36.

Halyard Health (NYSE:HYH) last posted its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 EPS for the quarter, topping the consensus estimate of $0.37 by $0.14. Halyard Health had a net margin of 3.06% and a return on equity of 8.29%. The business had revenue of $399.20 million for the quarter, compared to the consensus estimate of $399.16 million. During the same period last year, the company earned $0.45 EPS. The firm’s revenue was down .2% compared to the same quarter last year. On average, equities research analysts forecast that Halyard Health, Inc. will post $1.98 EPS for the current year.

A number of equities analysts have weighed in on the stock. Stephens raised shares of Halyard Health from an “equal weight” rating to an “overweight” rating in a research note on Thursday, August 3rd. BidaskClub raised shares of Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 19th. Deutsche Bank AG boosted their target price on shares of Halyard Health from $35.00 to $42.00 and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Zacks Investment Research raised shares of Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 target price for the company in a research note on Wednesday, July 12th. Finally, TheStreet raised shares of Halyard Health from a “c” rating to a “b” rating in a research note on Thursday, June 22nd. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $42.25.

TRADEMARK VIOLATION NOTICE: This article was first reported by Transcript Daily and is owned by of Transcript Daily. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://transcriptdaily.com/2017/09/17/halyard-health-inc-hyh-shares-bought-by-jpmorgan-chase-co.html.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply